Thursday, June 11, 2026

IJID: Regional Signals Preceding the 2026 Bundibugyo Virus Disease Outbreak

 

#19,198

When the Bundibugyo Ebola virus outbreak in the DRC was announced nearly 4 weeks ago, there were already 246 suspected cases and 65 deaths, which suggested the outbreak had been brewing - unrecognized - for several months.

Which isn't to say it went unnoticed, for in the 3 months prior there were a number of reports from the region of `suspected' hemorrhagic fever cases that were either never confirmed, or followed up on.

Admittedly, outbreaks in the DRC are notoriously difficult to manage, as much of the region is a conflict zone, is plagued by a wide variety of infectious diseases, and has only limited public health capacity.  Also, the Ebola PCR test commonly used in the region was Zaire-specific, and would not have detected the much rarer Bundibugyo virus.  

But gaps in surveillance and reporting extend far beyond Central Africa.

As we've discussed often (see Flying Blind in the Viral Storm), over the past few years we've seen a noticeable decline in surveillance and reporting of infectious diseases around the world.

In 2005 the World Health Organization adopted updated IHR (International Health Regulations) which – among other things - required countries to develop mandated surveillance and testing systems, and to report certain types of disease outbreaks and public health events to WHO.
Member states had until mid- 2012 to meet core surveillance and response requirements, but many nations failed to meet that deadline, which has forced the WHO to grant repeated extensions.  

A report 3 years ago (see Lancet Preprint: National Surveillance for Novel Diseases - A Systematic Analysis of 195 Countries), found many member nations still lack the capability to fully investigate cases.

And of course, some nations - for political or economic reasons - simply choose to ignore the IHR whenever convenient, since there are few tangible penalties for doing so (see From Here To Impunity).

Today we've a fascinating look at early signals - and missed opportunities - in the DRC going back to early March of this year. 

While not a long report, I've only posted the Abstract. Follow the link to read the full report.  

Regional Signals Preceding the 2026 Bundibugyo Virus Disease Outbreak

Nahid Bhadelia1,2 ∙ Isaac Gikandi1 ∙ Britta Lassmann1,2

Highlights
    • Bundibugyo virus circulated undetected for months prior to outbreak declaration.
    • Four earlier regional hemorrhagic fever clusters flagged by open surveillance are unresolved.
    • These clusters warrant urgent reanalysis due to concern for regional spread.
Abstract

Background

 The May 2026 Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo was declared a Public Health Emergency of International Concern after substantial undetected community transmission. We describe regional surveillance signals detected by the Biothreats Emergence, Analysis, and Communications Network (BEACON), our open access event based surveillance program, in the weeks preceding outbreak declaration.

Methods

We reviewed BEACON reports of VHF-compatible illness clusters detected in the transboundary DRC-Uganda-Burundi-South Sudan region during March–April 2026, prior to the May 15 laboratory confirmation of BDBV.

Results

BEACON detected four temporally proximal VHF-compatible illness signals:
  • (1) March 9, North Kivu Province—suspected Ebola case under investigation with unresolved laboratory results;
  • (2) March 10, Kasaï Province—fatal hemorrhagic illness with secondary cases and negative Ebola PCR;
  • (3) March 30, Burundi—35-case undiagnosed cluster near the DRC border with 5 deaths, negative testing for major filoviruses and >200 pathogens, pending metagenomic sequencing;
  • (4) April 22, South Sudan—three suspected VHF cases with negative initial testing. 
All four signals shared a similar diagnostic phenotype: VHF-compatible presentation, mobilization of investigation teams, negative initial testing, and no publicly reported confirmed etiology. None were formally reported to have been resolved.

Conclusions

Our detection of four unresolved VHF signals preceding the confirmed BDBV outbreak highlights gaps in formal follow-up mechanisms for negative cases and fragmented regional diagnostic coordination. In light of confirmed BDBV circulation and Africa CDC's identification of 10 countries at high risk for spread, these preceding signals warrant urgent retrospective investigation and laboratory.
When the World Health Organization (WHO) declared the Bundibugyo disease outbreak in the Democratic Republic of the Congo (DRC) and Uganda a Public Health Emergency of International Concern on May 17, 2026, the epidemiology was already telling us we were late [1,2]. Eight of the first thirteen samples submitted to the Institut National de Recherche Biomédicale (INRB) returned positive for Bundibugyo virus.
By May 23, 746 suspected cases, 83 confirmed cases, 176 suspected deaths, and 9 confirmed deaths have been reported in DRC’s Ituri, North Kivu and South Kivu provinces, with spread to multiple urban centers. Uganda has 5 confirmed cases with direct epidemiological links to DRC [3].
There remains significant uncertainty about the true number of infections and how far the virus has spread. Healthcare worker deaths in clinical contexts consistent with viral hemorrhagic fever (VHF) had been reported in multiple sites. The official investigation was anchored, in retrospect, to the death of a nurse in Bunia on April 24, 2026, and to funeral-related exposures that followed. Recent data shows the outbreak began well before this date.
       (Continue . . . )


Wednesday, June 10, 2026

Nature: Host factors, inflammatory markers, and clinical outcomes of Naegleria fowleri meningoencephalitis

 

#19,197

Nearly every year I end up blogging about a rare, mostly fatal brain infection caused by free living amoebas (Naegleria fowleri) that inhabit warm, fresh water (see A Reminder About Naegleria Season - 2019).

Dubbed the `brain eating amoeba' by the press - this infection is called PAM (Primary amebic meningoencephalitis) - and occurs when the amoeba enters the brain through the nasal passages, usually due to the forceful aspiration of contaminated water into the nose.

Not every PAM case is due to Naegleria, as Balamuthia mandrillaris and Acanthamoeba - and other non-Naegleria amoebic infections - can cause similar pathologies. 

As a thermophilic (heat-loving), free-living amoeba, it is hardly surprising that Naegleria is mainly reported during the summer - and that Florida and Texas lead the nation in cases over the past three decades - although infections have occurred as far north as Minnesota.

Last year the CDC's MMWR carried a report on a fatal 2024 case from Texas, which involved a previously health 71-year old woman who used unsterilized water to perform nasal irrigation.  

This is a common way that people around the world have become infected (see 2011's Neti Pots & Naegleria Fowleri).  The CDC and state health departments have long warned on the dangers of using tap water to perform nasal irrigation, and offer advice on safer alternatives. 

For a more detailed look as PAM risks from nasal irrigation, you may with to revisit EID Journal: (Mis)perception and Use of Unsterile Water in Home Medical Devices.

Other routes of infection include swimming in stagnant, warm fresh water ponds, attending water parks, and even in a child playing with a water hose in their own yard. 

Only 3 or 4 cases are reported in the United States each summer, but in 2017 a research letter written by epidemiologists at the CDC (see EID Journal: Estimation of Undiagnosed Naegleria fowleri (PAM), United States) estimated the yearly number PAM cases in the United States probably averages closer to 16 (8 males, 8 females).

Meaning that 70%-80% likely go unrecognized. 

Every year Pakistan reports a dozen or more infections from this `killer amoeba’, as chlorination of their water supplies is often inadequate, and for many, nasal ablutions are part of their daily ritual.

But in 2025 Kerala, India saw an unprecedented outbreak (see The outbreak of amoebic meningoencephalitis in Kerala: A wake-up call`with with reports indicating a total of 129 cases and 26 deaths as of October 18, 20251.'

Even more remarkable than the sharp rise in cases was the unusually low fatality rate - which normally exceeds 90% - even with treatment. 

Since it was published 2 weeks after the Hantavirus outbreak aboard the m/v Hondius and 4 days after the announcement of a large Bundibugyo virus outbreak in Africa, the following study - published in Nature - probably didn't garner as much attention as it should.

In short, this study looked at a cohort of roughly 200 PAM patients from Kerala, India treated between January and November 2025 using a standardized amphotericin B/miltefosine protocol

Roughly of 1/3rd of cases were unresolved at the time of the cut off, and were not included in the analysis - but of the 134 who were 61 died,  while 73 recovered, giving a case fatality rate of 45.5%. 

Given this remarkable success rate, and the increasing risk of PAM due to climate change, the following report should be of particular interest to clinicians.


Abstract

Background

Primary amoebic meningoencephalitis (PAM) caused by Naegleria fowleri carries historical case fatality rates (CFR) exceeding 97%. The 2025 Kerala outbreak, the largest documented globally, provided an unprecedented opportunity to identify host factors and inflammatory correlates influencing survival under standardised management.

Methods

We conducted a prospective observational study of 200 laboratory-confirmed PAM cases across six districts of Kerala, India (January–November 2025). All patients received protocolised amphotericin B ± miltefosine. Demographic, clinical, and laboratory data were collected, including inflammatory biomarkers (IL-6, TNF-α, IL-1β, neutrophil-to-lymphocyte ratio), pathogen burden (qPCR), and treatment timing. Multivariable logistic regression identified mortality predictors; bootstrap resampling and E-value sensitivity analyses assessed robustness.

Results

Here we show that among 200 patients (median age 41 years; 50% male), 134 with resolved outcomes yield a CFR of 45·5% (95% CI 37·3–54·5%; 61 deaths, 73 recoveries). Diabetes mellitus is the only statistically significant predictor of mortality in the adjusted model (adjusted OR 2·59; 95% CI 1·01–6·66; p = 0·048), though the proximity of the lower confidence bound to unity warrants cautious interpretation. This association remains consistent across sensitivity analyses (bootstrap 95% CI 1·06–8·74; E-value 4·62). Asthma demonstrates a protective association in univariable analysis (OR 0·37; p = 0·021), though this finding remains hypothesis-generating. Early treatment (≤2 days) shows a trend toward improved survival (p = 0·084). Inflammatory biomarkers show no association with outcome, though CSF pathogen burden correlates significantly with admission neurological severity.

Conclusions

Under standardised treatment, diabetes mellitus emerges as a key host determinant of PAM mortality. The dissociation between inflammatory markers and outcomes suggests neurological fate may be determined early in infection, with immediate clinical implications as climate change expands the geographic range of N. fowleri.

Plain language summary

Naegleria fowleri is an amoeba found in warm freshwater that can cause a rare but usually fatal brain infection. Historically, more than 97% of people who develop this infection die. In 2025, a large outbreak occurred in Kerala, India, affecting 200 people. We studied these patients to understand what factors influenced survival. The death rate was 45.5%, much lower than expected, likely because all patients received the same standard drug treatment. People with diabetes were roughly twice as likely to die as those without. Surprisingly, common markers of inflammation did not help predict who would survive. As climate change warms freshwater sources worldwide, understanding what determines survival from this infection becomes increasingly important
.

       (Continue . . . )

  

Tuesday, June 09, 2026

Preprint: The canine respiratory epithelium is a permissive ecosystem for influenza interspecies transmission and emergence

 

#19,196

Until 2004, dogs were considered relatively immune to influenza, but that changed abruptly when an equine H3N8 virus spilled over to dogs at a Florida racetrack, and began its world tour.

Three years later, an avian H3N2 virus spilled over to dogs in South Korea, and spread across Asia, eventually arriving in the United States in 2015.

In 2010, in Morens & Taubenberger on Influenza’s History, we looked a a fascinating 11-page historical review of Influenza outbreaks amongst a variety of hosts (human, avian, equine, porcine, canine, etc.) going back more than 3,000 years by Jeffrey K. Taubenberger and David Morens.

They cited a number of pandemics where anecdotal accounts mentioned dogs falling ill, either before - or concurrent to - when human cases emerged.

Since then we've looked at a lot of studies on dogs and flu, including: 

While dogs are more apt to have less severe flu illness than cats - making infections easier to miss - there is little doubt they are susceptible.  Unknown, however, is whether they are mostly a dead-end host, or if they are capable to transmitting the virus to others. 

Today we've got a preprint from researchers in the UK which attempts to better understand the risks. Using canine lung explants, they find that dogs are a plausible host for influenza reassortment, as they contain both human-type (α2,6) and avian-type (α2,3) receptor cells.

The caveats being that this is an ex vivo study, and is subject to a number of limitations (see below), and there is currently no evidence that novel influenza viruses are spreading efficiently among canines. 

But the only constant with influenza viruses is that they change, making today's status tenuous at best.  Due to its length, I've only posted some excerpts. Follow the link to read the report in its entirety.  


The canine respiratory epithelium is a permissive ecosystem for influenza interspecies transmission and emergence
Hanting Chen, Jack Hassard, Jiayun Yang, Callum Magill, Toby Carter, Jean-Remy Sadeyen, Aimi Ito, Clio Duerr,  Hannah Rose Montgomery, Savitha Raveendran, Kieran Dee,  Maximillian N J Woodall, Grace B Tyson, Maria M Afonso, Verena Schultz,  Claire Mary Smith,  Margaret J Hosie, Stuart Haslam, Munir J Iqbal,  Pablo R Murcia
doi: https://doi.org/10.64898/2026.06.04.730051
This article is a preprint and has not been certified by peer review
 

Preview PDF

Abstract

The outcome of virus spillover ranges from dead-end infections to pandemics and is underpinned by host-pathogen interactions as well as evolutionary and epidemiological processes. The emergence of novel influenza A viruses (IAVs) has been associated with reassortment events involving multiple species, highlighting the importance of reservoir and intermediate hosts in viral emergence.
Highly pathogenic H5N1 IAVs of the 2.3.4.4b genotype have caused a panzootic affecting a broad range of mammals. The role of dogs -arguably the most popular companion animal and a natural host of IAVs- in the ecology of IAVs under this new zooepidemiological scenario is unknown. To address this, we characterised the glycome of the dog respiratory epithelium, infected canine tracheal explants with multiple IAVs (including canine H3N2 and H3N8, equine H3N8, avian H3N8 and H5N1, swine H1N1, human H1N1 and H3N2, and bovine H5N1 viruses), and determined their cellular tropism.
We show that the respiratory tract of dogs presents abundant sialylated glycans known to act as IAV receptors. Further, most IAVs (including 2.3.4.4b viruses) infected and replicated in dog tracheas, targeting mainly ciliated cells. Serological testing showed evidence of influenza spillover infections in dogs from the UK.
Overall, our results show that the canine respiratory tract can provide a suitable environment for the generation of new IAVs. Given the multi-host contact networks of dogs in nature, they could act as recipients, bridging hosts, and/or mixing vessels for multiple IAV lineages, playing a central role in the ecology of influenza emergence.

(SNIP) 

Our results suggest that dogs could act as a bridging species for the emergence of novel IAVs, including the H5N1 2.3.4.4b genotype. Serological studies in North America and Europe show that hunting dogs are routinely exposed to H5N1 IAVs 53,54. 

Vaccination of high-risk dog subpopulations could reduce the risk ofinter species infections (avian-to-dog and dog-to-human) and should be considered as preventative measures. 

This study has various limitations. Tracheal explants represent a significant portion of the airways, but this experimental system does not include the upper respiratory tract, the bronchial tree, nor the pulmonary parenchyma, which are likely to exhibit different virus/host interactions due to the presence of different cell types.

Further, explants lack systemic responses that are normally mounted during viral infections. Despite these limitations, our results are consistent with observations reported in field studies 59,60 and experimental in vivo infections 26,27

In sum, influenza spillover and emergence require a succession of processes that occur at different scales8. As the canine respiratory tract is a suitable ecosystem for IAV infection and reassortment and dogs routinely interact with multiple species that support endemic IAVs, dogs could facilitate the flow of virus between sympatric species. Targeted approaches to reduce the risk of IAV infections in dogs should be part of preparedness efforts to control influenza cross-species switching. 

       (Continue . . . ) 


 

Monday, June 08, 2026

USDA: 2 More Screwworm Detections in Texas

 
USDA Screwworm Dashboard -Updated


Update: The USDA has clarified that the dog mentioned infected in yesterday's post was from New Mexico, not Texas. 

 #19,195

Although the USDA's website and Screwworm Dashboard (above) have not been updated yet, this morning the USDA emailed the following update, which adds two more cases - and importantly - from 2 new counties. 

The calf in La Salle county is adjacent to Zavala County, where the first two cases were identified, but the dog in Andrews County is roughly 300 miles north and west.  
There is a possibility the dog was exposed in Mexico, but the epidemiological investigation is ongoing. I'll update this post when the USDA updates their website.
           
        (via Email)
USDA Confirms Two Additional Cases of New World Screwworm in the United States
The State of Texas continues to lead response with USDA support.

WASHINGTON, D.C., June 8, 2026 – Today, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed two additional cases of New World screwworm (NWS) in the United States – a calf in La Salle County, Texas, and a dog in Andrews County, Texas.

Epidemiological investigations are ongoing for both cases. A veterinarian in Andrews County submitted the samples from the infested dog. Details on this case will be shared as they are available, but early reports indicate the dog was recently in Mexico.

NWS is a serious pest that threatens livestock, pets, wildlife, and, in rare cases, people. The larvae burrow into the living tissue of animals, causing severe wounds, animal suffering, and significant economic losses.

“Over the past week, USDA has identified and expeditiously confronted four confirmed detections of New World screwworm. While we address these instances that require immediate attention, and continue to sample suspected cases, we are simultaneously working to eradicate the pest entirely,” said Dudley Hoskins, Under Secretary for Marketing and Regulatory Programs. “We need the partnership of animal owners across the region – please stay vigilant, check your animals closely, and report anything that looks suspicious. Together, we can protect our livestock, our communities, and the health of animals nationwide.”
USDA and TAHC Response

USDA and the Texas Animal Health Commission (TAHC) continue to lead an aggressive unified response, with a total of 75 people actively responding on the ground and hundreds of additional people around the country providing laboratory diagnostics, logistics, treatment distribution, air operations, outreach, operational planning, and resource support for the response. APHIS and TAHC will continue to surge additional trained personnel as needed to ensure an effective response.

For each new case, USDA and TAHC implement actions outlined in the NWS Response Playbook, including:
  • Establishing and maintaining a 20km infested zone with quarantines, movement controls, and heightened surveillance around confirmed detections
  • Increasing trapping along the border and outside the dispersal zone
  • Conducting surveillance and management strategies in wildlife
  • Implementing targeted outreach to local producers, veterinarians, and communities
Intensified Sterile Fly Releases

USDA continues to release sterile flies over and just outside of the infested areas. To ensure sterile fly release operations can be deployed to affected areas in Texas and in northern Mexico near the border as quickly and efficiently as possible, USDA has activated the sterile fly dispersal facility at Moore Air Base in Edinburg, Texas. Sterile pupae arrived at the facility on Friday, and aerial dispersal flights originating from the base will begin tomorrow.

Because it is important to continue ongoing surveillance efforts while releasing sterile insects, it is possible that sterile NWS flies could be caught and/or reported. To ensure officials can tell the difference between sterile and wild NWS flies, USDA dyes the sterile pupae, and the dye transfers to the sterile flies when they hatch. The fluorescent green or orange dye glows under UV light and may also be visible to the naked eye. If a sterile fly is captured in a trap, this dye allows animal health officials to quickly rule the fly out as a threat. 

       (Continue . . . )

 

EM&I: A new clade of H9N2 avian influenza virus circulating in Laos

 
In terms of risk of emergence, the H9N2
Y280 lineage is ranked higher than H5N1

#19,194

While LPAI H9N2 may not be the most headline grabbing avian flu virus, it is quite likely the most versatile. It is highly promiscuous, reassorting easily with many other subtypes (including H5Nx and H7Nx), it has diverged into numerous clades, and it continues to accrue mammalian adaptations.  

While testing and reporting of cases around the globe is limited, over the past 12 months more than 2 dozen human cases have been reported (see FluTrackers H9N2 case list).

As a result, H9N2 gets more than a little attention by researchers.

All of which brings us to a new report, published last week in Emerging Microbes & Infections, which describes a new clade of LPAI H9N2 recently discovered in Laos. 

A new clade of H9N2 avian influenza virus circulating in Laos

Jiaming Li ,Chunge Zhang ,Ren Li ,Yanqing Wang ,Rahat Ullah Khan ,Ruichang Quan 
Article: 2678641 | Received 05 Feb 2026, Accepted 19 May 2026, Published online: 04 Jun 2026
https://doi.org/10.1080/22221751.2026.2678641

ABSTRACT

In 2024, we identified and sequenced 52 avian influenza A (H9N2) virus strains in Laos. Using the established H9N2 genomic classification system, a novel HA gene clade of the A/chicken/Beijing/1/94-like (BJ/94-like) lineage, designated Clade 4.6.20, was identified.

This new clade is phylogenetically distinct from the previously described clades, and the representative strains in this new Clade 4.6.20 presented a low cross reactivity to the antisera of other clades, suggesting antigenic drift of the viruses between the new Clade 4.6.20, and other clades in the dominant lineage of Clade 4.6.

In addition, all the newly identified viruses in Clade 4.6.20 possessed HA-L226 and NP-N52 mutations, which are associated with human-type receptor binding and human MxA-related innate immunity escape, respectively.

Our findings underscore the necessity of global surveillance network and cooperation to monitor the evolution of AIVs, update vaccine seed strains, and develop new vaccines with high effectiveness against H9N2 AIVs circulating globally, which threaten poultry and human health.

        (SNIP)

In conclusion, the identification of a novel H9N2 clade (Clade 4.6.20) in Laos suggests that influenza viruses including both avian and human viruses may undergo undetected evolutionary changes in regions with inadequate surveillance, posing significant public health threats. This highlights the need to enhance international collaboration, improve surveillance systems, and develop new vaccines and NPIs to mitigate the increasing risks associated with cross-border viral spread and zoonotic transmission.

        (Continue . . .) 

This is the second `novel' LPAI H9N2 virus discovery reported in less than a month, and it comes just a couple of months after Europe's first imported H9N2 case (from West Africa)

While primarily an avian virus, LPAI H9N2 has a track record of also  infecting humans, pigs, and even bats (see Preprint: The Bat-borne Influenza A Virus H9N2 Exhibits a Set of Unexpected Pre-pandemic Features).
China's attempts to control this rapidly evolving H9N2 virus with poultry vaccines have proved disappointing (see J. Virus Erad.: Ineffective Control Of LPAI H9N2 By Inactivated Poultry Vaccines - China).

And last year, in NPJ Vaccines: Impact of Inactivated Vaccine on Transmission and Evolution of H9N2 Avian Influenza Virus in Chickens, we saw evidence that not only had inactivated vaccines failed to prevent - or even reduce - H9N2 in China's poultry, they may have driven viral evolution (including mammalian adaptations).

Despite all of this - because it is not a high-risk H5 or H7 avian virus - H9N2 remains a `non-reportable' disease in poultry (see Terrestrial Animal Code Article 10.4.1.), allowing much of its spread and evolution to fly under the radar.

Hopefully these recent reports will spur additional surveillance, because - contrary to popular belief - what we don't know can hurt us. 

ECDC MERS-CoV Update: 2 Cases Reported By Saudi Arabia in 2026



#19,193

Although the number of MERS-CoV cases reported over the past few years has fallen dramatically, this high morbidity/mortality coronavirus continues to pose a significant public health threat ((Referral) Nature: Human MERS-CoV cases are falling but pose an ongoing pandemic threat) as it spreads and evolves in camels in the Middle East and Africa. 

Admittedly, we've seen more than a little reluctance on the part of Middle Eastern nations to report casesAnd it seems likely that cases are being missed in North and Central Africa as well (see EID Journal: Geographic Distribution of MERS-CoV among Dromedary Camels, Africa).

Both EID Journal: Estimation of Severe MERS Cases in the Middle East, 2012–2016 and Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study by Drosten & Memish et al., suggest that far more MERS-CoV cases have occurred than have been reported.

Last December, France reported 2 Travelers Returning From Arabian Peninsula Diagnosed with MERS-CoV, but thus far in 2026 all has been quiet. Saudi Arabia only reports every 6 months, but last Friday the ECDC carried a very brief report on two recent (March & April) cases.

Details are scant, but we know that one case was fatal, and the source of exposure for both cases are unknown. First the report, then I'll return with a bit more after the break.
Middle East respiratory Syndrome coronavirus (MERS-CoV) – Multi-country –Monthly update

Overview

Update: Since the previous update on 4 May 2026, and as of 1 June 2026, two new MERS cases, including one fatality, in Saudi Arabia have been reported by the World Health Organization (WHO) Eastern Mediterranean Regional Office (EMRO). Both cases are male adults and have unknown source of infection. One case had date of reporting in March 2026 and the fatal case had date of reporting in April 2026.

Summary: Since the beginning of 2026, and as of 1 June 2026, two MERS cases, including one fatality, have been reported in Saudi Arabia.

Since April 2012, and as of 1 June 2026, a total of 2 649 MERS cases, including 960 deaths, have been reported by health authorities worldwide. 

Sources:  ECDC MERS-CoV page | WHO MERS-CoV | ECDC factsheet for professionals | Qatar MoPH Case #1 |Qatar MoPH Case #2 | FAO MERS-CoV situation update | WHO DON Oman | WHO DON Saudi Arabia | WHO DON UAE | WHO DON Saudi Arabia 1 | WHO IHR | WHO EMRO MERS Situation report | WHO DON Saudi Arabia 2 |WHO DON Saudi Arabia 3 | WHO DON Saudi Arabia 4 | WHO DON Saudi Arabia 5 | MERS-CoV Dashboard | French Ministry of Health | WHO DON France & Saudi Arabia 

ECDC assessment 

Human MERS cases continue to be reported in the Arabian Peninsula. However, the number of new cases detected and reported through surveillance has dropped to the lowest level since 2014. The probability of sustained human to-human transmission among the general population in Europe remains very low and the impact of the disease in the general population is considered low. The current MERS-CoV situation remains unchanged and poses a low risk to the EU/EEA, as stated in the Rapid Risk Assessment published by ECDC on 29 August 2018.

ECDC published a technical report, 'Health emergency preparedness for imported cases of high-consequence infectious diseases', in October 2019 that is still useful for EU Member States wishing to assess their level of preparedness for a disease such as MERS. ECDC also published 'Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) – Middle East respiratory syndrome coronavirus (MERS-CoV)' on 22 January 2020.ActionsECDC is monitoring this situation through its epidemic intelligence activities and reports on a monthly basis or when  new epidemiological information is available
Prior to COVID's emergence in late 2019, MERS-CoV was the top contender for sparking a coronavirus pandemic, sporting a high mortality rate (>30%), and spreading easily through hospitals in the Middle East (and South Korea) (see Ziad Memish: Two MERS-CoV Hospital Super Spreading Studies).

A year ago we looked at an editorial in Journal of Epidemiology & Global Health on the importance of continued healthcare preparedness and surveillance (see Al-Tawfiq & Memish On Recurrent MERS-CoV Transmission in Saudi Arabia), with an emphasis on identifying asymptomatic carriers.

Whether MERS-CoV will re-emerge as a global health threat remains unknown, but it continues to circulate  and evolve - largely out of our view - on both the Arabian Peninsula and in Africa.

Which makes it very much worth our attention.